Autoimmune Diseases  >>  Actemra SC (tocilizumab SC)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Actemra SC (tocilizumab SC) / Roche, Halozyme
ADACTA, NCT01119859 / 2009-015845-21: A Study of Tocilizumab (RoActemra/Actemra) Versus Adalimumab in Patients With Rheumatoid Arthritis

Checkmark Rheumatoid arthritis (ADACTA)
Apr 2014 - Apr 2014: Rheumatoid arthritis (ADACTA)
Checkmark Rheumatoid arthritis (ADACTA)
Apr 2014 - Apr 2014: Rheumatoid arthritis (ADACTA)
Checkmark ACR/ARHP 2013
More
Completed
4
326
US, Europe, RoW
Tocilizumab, RoActemra, Actemra, Adalimumab, Placebo to tocilizumab, Placebo to adalimumab
Hoffmann-La Roche
Rheumatoid Arthritis
01/12
01/12
NCT02682823: Tocilizumab Real-Life Human Factors (RLHFs) Validation Study

Completed
4
91
US
AI-1000 G2, Tocilizumab, Actemra/RoActemra, RO4877533
Hoffmann-La Roche
Rheumatoid Arthritis
07/16
07/16

Download Options